Main content

Wiki | home Discussion

Home

Toggle view:
View
Compare
View
Wiki Version:

The Reproducibility Project: Cancer Biology was an initiative to independently replicate selected experiments from a number of high-profile papers in the field of cancer biology. In the end 50 experiments from 23 papers were repeated. The final two outputs from the project recount in detail the challenges the project team encountered while repeating these experiments ('Challenges for assessing replicability in preclinical cancer biology'), and report the results of a meta-analysis that combined the results from all the experiments ('Investigating the replicability of preclinical cancer biology'). The project was a collaboration between the Center for Open Science and Science Exchange.


Visit the overview page for additional details about the project, press & news, and how to get involved.

Visit the eLife collection for all published papers.

Visit the OSF collection for all associated digital content including the aggregate dataset.


Replication Study Results

Each replication was organized on the Open Science Framework (OSF). The OSF is a free service and is where all the experimental protocols, materials, data, analysis, and results were made openly available. Furthermore, the Registered Reports format was used, in which peer review of proposed experimental designs and protocols were conducted prior to data collection, in conjunction with eLife with the results published in a Replication Study.


A total of 50 experiments from 23 papers were completed. This resulted in 17 Replication Studies published at *eLife*, 1 Replication Study posted as a preprint, and the remaining completed experiments reported in a summary paper. Details for all papers below:

Experiments from unfinished Registered Reports in the Reproducibility Project: Cancer Biology

Replication Study: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

Replication Study: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs

Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

Replication Study: Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis

Replication Study: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Replication Study: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota

Replication Study: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma

Replication Study: Transcriptional amplification in tumor cells with elevated c-Myc

Replication Study: Systematic identification of genomic markers of drug sensitivity in cancer cells

Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

Replication Study: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

Replication Study: Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

Replication Study: BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

Replication Study: Discovery and Preclinical Validation of Drug Indications using Compendia of Public Gene Expression Data

Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

  • View the Replication Study results published in eLife.
  • Access the OSF Project page, which contains all data, methods, and materials pertaining to the replication of this Replication Study.
  • View the Registered Report, which contains detailed, peer-reviewed, protocols for this replication.

Replication Study: Melanoma genome sequencing reveals frequent PREX2 mutations


Additional articles and commentary published on this project:

For more information read the Introductory commentary published by eLife that introduces and summarizes the project and the corresponding editorial as well as the Replication commentary and the corresponding editorial from eLife from the first published Replication Studies. The final eLife editorial and an independent commentary compliment the final summary papers.


What were the aims of the project?

Through independent direct replication studies, the project aimed to identify best practices that maximize reproducibility and facilitate an accurate accumulation of knowledge, enabling potentially impactful novel findings to be effectively built upon by the scientific community.

Additionally we expected to learn about:

  • The overall rate of reproducibility in a sample of the published cancer biology literature.
  • Obstacles that arise in conducting direct replications of original studies.
  • The feasibility and practical challenges of getting proper materials, methods, and instrumentation for a replication.
  • Predictors of replication success.

Questions or interest in the project can be directed to contact+rpcb@cos.io.


OSF does not support the use of Internet Explorer. For optimal performance, please switch to another browser.
Accept
This website relies on cookies to help provide a better user experience. By clicking Accept or continuing to use the site, you agree. For more information, see our Privacy Policy and information on cookie use.
Accept
×

Start managing your projects on the OSF today.

Free and easy to use, the Open Science Framework supports the entire research lifecycle: planning, execution, reporting, archiving, and discovery.